ASGR1 and hepatocellular carcinoma: A significantly greater proportion of aHCC and eHCC patients had CECs (including ASGR+ and ASGR-) compared with LC (p = 0.049) (Figure 4C) and this increase came with a significant reduction on the number of CECs expressing ASGR1 in HCC compared to LC (p = 0.003) (Figure 4D).